News

2017

ReachBio Research Labs Offers New NK (V158+) Cells Optimized for ADCC Assays online

May 09, 2017

SEATTLE, May 9, 2017 -- ReachBio Research Labs (trade name under ReachBio LLC), a CRO specializing in primary cell assay services and products, is now offering sourced, enriched and tested primary....

ReachBio's COO, Rob Chaney, talks cellPrism® and growth with CEOCFO Magazine

April 24, 2017

Rob Chaney, Co-Founder, COO & General Manager

Applied Pharmaceutical Toxicology 2017

April 17, 2017

We're excited to announce we'll be exhibiting at this year's Applied Pharmaceutical Toxicology (APT) Conference  in San Francisco, California at Genentech in building 35, May 15th - 17th.

SOT 56th Annual Meeting and ToxExpo

February 15, 2017

We’re happy to announce we’ll be exhibiting at this year’s ToxExpo at the Society of Toxicology (SOT) 56th Annual Meeting in Baltimore, Maryland. Our booth, #1616, will display a range of....

ReachBio Research Labs Launches a New Drug Development Platform, cellPrism®

January 31, 2017

SEATTLE, Jan. 31, 2017 /PRNewswire/ -- ReachBio Research Labs (trade name under Reachbio LLC®) has announced the launch of their new drug development platform, cellPrism®. The platform is designed to....

2016

Human PBMCs Available Online

June 20, 2016

ReachBio Research Labs now makes it easy for you to purchase Human Peripheral Blood Mononuclear Cells (PBMCs) online! All blood is obtained from healthy human donors under IRB-approved protocols....

World Preclinical Congress 2016

June 01, 2016

Join us June 15-17, 2016 at the 15th Annual World Preclinical Congress in Boston, MA! Stop by booth #207, and meet our CSO, Dr. Emer Clarke, and Lead Scientist, Gary dos Santos.

Society of Toxicology 55th Annual Meeting and ToxExpo

March 04, 2016

The Society of Toxicology 55th Annual Meeting and ToxExpo is next week! We’ll be exhibiting at ToxExpo, March 14-16. Stop by booth #1300 to talk one-on-one with our scientists, CSO, Dr. Emer Clarke,....

2015

Happy New Year from ReachBio Research Labs!

December 31, 2015

It’s been a good year for growth at ReachBio Research Labs! We’ve really enjoyed working with our existing clients, new clients and those who’ve come back with new contract service and/or product....

Thank you for visiting us at ACT 2015!

November 12, 2015

Thank you to everyone who took the time to visit with us at the American College of Toxicology (ACT) 2015 36th Annual Meeting, this week. We had a great time, and look forward to seeing everyone,....

2014

Effects of Compounds on Thrombopoiesis: Beyond the CFU-Mk Colony Assay

September 11, 2014

The CFU-Mk assay is a robust and predictive in vitro assay for evaluating the toxicity of test compounds on megakaryocytic progenitors. However, sometimes compounds can effect overall thrombopoiesis....

Hemotoxicity Testing: Predictive Lineage-Specific In Vitro Assay Services by ReachBio Research Labs

May 12, 2014

If your drug development program has a particular lineage-specific hemotoxicity issue such as neutropenia (myeloid lineage toxicity), acute anemia (erythroid lineage toxicity) or thrombocytopenia....

ReachBio's Posters Presented at SOT 2014 Are Now Available to Download

April 10, 2014

Interested in in vitro assays to assess the risk of cytokine storms? Or in vitro evaluation of compound effects on leukemic progenitors vs normal progenitors? So are we!

SOT 2014

February 27, 2014

SOT 2014 Posters Available for Download!

ReachBio Research Labs presented the following posters at the recent Society of Toxicology conference in Phoenix, AZ. Click on the title to download a copy.

"....

Hemotoxicity Testing Services - Are you Eligible for Multi-Assay Discounts?

February 15, 2014

Our in vitro hemotoxicity testing services can provide valuable predictive information regarding compound-induced hemotoxicity on specific lineages: myeloid (CFU-GM assays), erythroid (BFU-E assays)....